TY - JOUR
T1 - ESC Council on hypertension position document on the management of hypertensive emergencies
AU - van den Born, Bert-Jan H
AU - Lip, Gregory Y H
AU - Brguljan-Hitij, Jana
AU - Cremer, Antoine
AU - Segura, Julian
AU - Morales, Enrique
AU - Mahfoud, Felix
AU - Amraoui, Fouad
AU - Persu, Alexandre
AU - Kahan, Thomas
AU - Agabiti Rosei, Enrico
AU - de Simone, Giovanni
AU - Gosse, Philippe
AU - Williams, Bryan
PY - 2019/1
Y1 - 2019/1
N2 - Hypertensive emergencies are those situations where very high blood pressure (BP) values are associated with acute organ damage, and therefore, require immediate, but careful, BP reduction. The type of acute organ damage is the principal determinant of: (i) the drug of choice, (ii) the target BP, and (iii) the timeframe in which BP should be lowered. Key target organs are the heart, retina, brain, kidneys, and large arteries. Patients who lack acute hypertension-mediated end organ damage do not have a hypertensive emergency and can usually be treated with oral BP-lowering agents and usually discharged after a brief period of observation.
AB - Hypertensive emergencies are those situations where very high blood pressure (BP) values are associated with acute organ damage, and therefore, require immediate, but careful, BP reduction. The type of acute organ damage is the principal determinant of: (i) the drug of choice, (ii) the target BP, and (iii) the timeframe in which BP should be lowered. Key target organs are the heart, retina, brain, kidneys, and large arteries. Patients who lack acute hypertension-mediated end organ damage do not have a hypertensive emergency and can usually be treated with oral BP-lowering agents and usually discharged after a brief period of observation.
KW - Hypertensive crisis
KW - Hypertensive emergency
KW - Hypertensive encephalopathy
KW - Hypertensive urgency
KW - Malignant hypertension
KW - Antihypertensive Agents/administration & dosage
KW - Humans
KW - Risk Factors
KW - Emergencies
KW - Hypertension/complications
KW - Treatment Outcome
KW - Consensus
KW - Disease Progression
KW - Blood Pressure/drug effects
UR - http://www.scopus.com/inward/record.url?scp=85055415578&partnerID=8YFLogxK
U2 - 10.1093/ehjcvp/pvy032
DO - 10.1093/ehjcvp/pvy032
M3 - Journal article
C2 - 30165588
SN - 2055-6837
VL - 5
SP - 37
EP - 46
JO - European heart journal. Cardiovascular pharmacotherapy
JF - European heart journal. Cardiovascular pharmacotherapy
IS - 1
ER -